BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol. 2005;148:107-121. [PMID: 15912030 DOI: 10.1159/000086055] [Cited by in Crossref: 169] [Cited by in F6Publishing: 148] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Della Coletta Francescato H, Cunha FQ, Costa RS, Barbosa Júnior F, Boim MA, Arnoni CP, da Silva CG, Coimbra TM. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage. Nephrol Dial Transplant 2011;26:479-88. [PMID: 20656754 DOI: 10.1093/ndt/gfq447] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
2 Zirak MR, Rahimian R, Ghazi-khansari M, Abbasi A, Razmi A, Ejtemaei Mehr S, Mousavizadeh K, Dehpour AR. Tropisetron attenuates cisplatin-induced nephrotoxicity in mice. European Journal of Pharmacology 2014;738:222-9. [DOI: 10.1016/j.ejphar.2014.05.050] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
3 Rasoulian B, Jafari M, Mahbod M, Dehaj ME, Nowrozi M, Wahhabaghai H, Mofid M, Ghasemi A, Bigdeli MR, Khoshbaten A. Pretreatment with Oxygen Protects Rat Kidney from Cisplatin Nephrotoxicity. Renal Failure 2010;32:234-42. [DOI: 10.3109/08860221003592838] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
4 Chakraborty P, Roy SS, Sk UH, Bhattacharya S. Amelioration of cisplatin-induced nephrotoxicity in mice by oral administration of diphenylmethyl selenocyanate. Free Radic Res 2011;45:177-87. [PMID: 20942565 DOI: 10.3109/10715762.2010.521155] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
5 Moghadasali R, Azarnia M, Hajinasrollah M, Arghani H, Nassiri SM, Molazem M, Vosough A, Mohitmafi S, Najarasl M, Ajdari Z, Yazdi RS, Bagheri M, Ghanaati H, Rafiei B, Gheisari Y, Baharvand H, Aghdami N. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model. Cytotherapy. 2014;16:734-749. [PMID: 24801377 DOI: 10.1016/j.jcyt.2014.01.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
6 Elsayed AM, Abdelghany TM, Akool el-S, Abdel-Aziz AA, Abdel-Bakky MS. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway. Naunyn Schmiedebergs Arch Pharmacol 2016;389:327-37. [PMID: 26659823 DOI: 10.1007/s00210-015-1193-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
7 Rjiba-touati K, Ayed-boussema I, Soualeh N, Achour A, Bacha H, Abid S. Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: Cisplatin and mitomycin C in cultured Vero cells. Exp Biol Med (Maywood) 2013;238:943-50. [DOI: 10.1177/1535370213494643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
8 Park HR, Jo SK, Cho HH, Jung U. Synergistic Anti-cancer Activity of MH-30 in a Murine Melanoma Model Treated With Cisplatin and its Alleviated Effects Against Cisplatin-induced Toxicity in Mice. In Vivo 2020;34:1845-56. [PMID: 32606154 DOI: 10.21873/invivo.11979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wu CT, Sheu ML, Tsai KS, Chiang CK, Liu SH. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model. Free Radic Biol Med 2011;51:671-80. [PMID: 21616140 DOI: 10.1016/j.freeradbiomed.2011.04.038] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
10 Mcwilliam L. Drug-induced renal disease. Current Diagnostic Pathology 2007;13:25-31. [DOI: 10.1016/j.cdip.2006.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Coling DE, Ding D, Young R, Lis M, Stofko E, Blumenthal KM, Salvi RJ. Proteomic analysis of cisplatin-induced cochlear damage: Methods and early changes in protein expression. Hearing Research 2007;226:140-56. [DOI: 10.1016/j.heares.2006.12.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
12 Tong F, Shen W, Song P, Song J, Hu Y, Liu F, Meng Z, Liu J. Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway. Biosci Rep 2021;41:BSR20204279. [PMID: 33558888 DOI: 10.1042/BSR20204279] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yang Y, Chen C, Duan P, Thapaliya S, Gao L, Dong Y, Yin X, Yang X, Zhang R, Tan R, Hui S, Wang Y, Sutton R, Xia Y. The ECG Characteristics of Patients With Isolated Hypomagnesemia. Front Physiol 2020;11:617374. [PMID: 33584338 DOI: 10.3389/fphys.2020.617374] [Reference Citation Analysis]
14 Rassnick KM, Muindi JR, Johnson CS, Balkman CE, Ramnath N, Yu WD, Engler KL, Page RL, Trump DL. In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemother Pharmacol 2008;62:881-91. [PMID: 18246349 DOI: 10.1007/s00280-008-0678-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
15 Waly MI, Al Moundhri MS, Ali BH. Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells. Ren Fail 2011;33:518-23. [PMID: 21574897 DOI: 10.3109/0886022X.2011.577546] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
16 Abo-Elmaaty AMA, Behairy A, El-Naseery NI, Abdel-Daim MM. The protective efficacy of vitamin E and cod liver oil against cisplatin-induced acute kidney injury in rats. Environ Sci Pollut Res Int 2020;27:44412-26. [PMID: 32767013 DOI: 10.1007/s11356-020-10351-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 2006;44:1173-83. [PMID: 16530908 DOI: 10.1016/j.fct.2006.01.013] [Cited by in Crossref: 210] [Cited by in F6Publishing: 176] [Article Influence: 14.0] [Reference Citation Analysis]
18 Santos NA, Bezerra CS, Martins NM, Curti C, Bianchi ML, Santos AC. Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother Pharmacol 2008;61:145-55. [PMID: 17396264 DOI: 10.1007/s00280-007-0459-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 7.9] [Reference Citation Analysis]
19 Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z. Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2007;293:F1282-91. [PMID: 17670903 DOI: 10.1152/ajprenal.00230.2007] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 11.6] [Reference Citation Analysis]
20 Kiilunen M, Aitio A, Santonen T. Platinum∗. Handbook on the Toxicology of Metals. Elsevier; 2015. pp. 1125-41. [DOI: 10.1016/b978-0-444-59453-2.00050-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Amuthan A, Devi V, Shreedhara CS, Rao V, Jasphin S, Kumar N. Vernonia cinerea regenerates tubular epithelial cells in cisplatin induced nephrotoxicity in cancer bearing mice without affecting antitumor activity. J Tradit Complement Med 2021;11:279-86. [PMID: 34012874 DOI: 10.1016/j.jtcme.2020.08.004] [Reference Citation Analysis]
22 Nolin TD, Himmelfarb J. Mechanisms of drug-induced nephrotoxicity. Handb Exp Pharmacol. 2010;111-130. [PMID: 20020261 DOI: 10.1007/978-3-642-00663-0_5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
23 Sahni V, Choudhury D, Ahmed Z. Chemotherapy-associated renal dysfunction. Nat Rev Nephrol 2009;5:450-62. [DOI: 10.1038/nrneph.2009.97] [Cited by in Crossref: 114] [Cited by in F6Publishing: 85] [Article Influence: 9.5] [Reference Citation Analysis]
24 Ibrahim A, Eldaim MA, Abdel-Daim MM. Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats. Cytotechnology 2016;68:1039-48. [PMID: 25720368 DOI: 10.1007/s10616-015-9860-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 7.7] [Reference Citation Analysis]
25 Kiilunen M, Aitio A. Platinum**The views presented in this chapter are those of the authors and do not necessarily reflect the decisions or stated policies of the affiliated organizations. Handbook on the Toxicology of Metals. Elsevier; 2007. pp. 769-82. [DOI: 10.1016/b978-012369413-3/50092-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
26 Kimura T, Nojiri T, Hosoda H, Ishikane S, Shintani Y, Inoue M, Miyazato M, Okumura M, Kangawa K. Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice. Cancer Chemother Pharmacol 2015;75:1057-63. [PMID: 25814217 DOI: 10.1007/s00280-015-2734-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
27 Fanzani A, Zanola A, Rovetta F, Rossi S, Aleo MF. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems. Toxicol Appl Pharmacol 2011;250:312-21. [PMID: 21074548 DOI: 10.1016/j.taap.2010.11.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
28 Ryu SH, Kim JW, Yoon D, Kim S, Kim K. Serum and urine toxicometabolomics following gentamicin-induced nephrotoxicity in male Sprague-Dawley rats. Journal of Toxicology and Environmental Health, Part A 2018;81:408-20. [DOI: 10.1080/15287394.2018.1451180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K-36K. [PMID: 16949378 DOI: 10.1016/j.amjcard.2006.01.022] [Cited by in Crossref: 261] [Cited by in F6Publishing: 218] [Article Influence: 17.4] [Reference Citation Analysis]
30 Yao S, Wei B, Yu M, Meng X, He M, Yao R. Design, synthesis and evaluation of PD176252 analogues for ameliorating cisplatin-induced nephrotoxicity. Medchemcomm 2019;10:757-63. [PMID: 31191866 DOI: 10.1039/c8md00632f] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Kennedy-Lydon T, Crawford C, Wildman SS, Peppiatt-Wildman CM. Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes. Am J Physiol Renal Physiol 2015;309:F648-57. [PMID: 26202223 DOI: 10.1152/ajprenal.00199.2015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
32 Jiang M, Wei Q, Pabla N, Dong G, Wang CY, Yang T, Smith SB, Dong Z. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol 2007;73:1499-510. [PMID: 17291459 DOI: 10.1016/j.bcp.2007.01.010] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 7.7] [Reference Citation Analysis]
33 Lameire N, Van Biesen W, Vanholder R. Electrolyte disturbances and acute kidney injury in patients with cancer. Semin Nephrol 2010;30:534-47. [PMID: 21146119 DOI: 10.1016/j.semnephrol.2010.09.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
34 Marković SD, Djačić DS, Cvetković DM, Obradović AD, Žižić JB, Ognjanović BI, Štajn AŠ. Effects of Acute In vivo Cisplatin and Selenium Treatment on Hematological and Oxidative Stress Parameters in Red Blood Cells of Rats. Biol Trace Elem Res 2011;142:660-70. [DOI: 10.1007/s12011-010-8788-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
35 Mohamed HE, El-Swefy SE, Mohamed RH, Ghanim AM. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats. Exp Toxicol Pathol 2013;65:197-203. [PMID: 21920723 DOI: 10.1016/j.etp.2011.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
36 Espandiari P, Rosenzweig B, Zhang J, Zhou Y, Schnackenberg L, Vaidya VS, Goering PL, Brown RP, Bonventre JV, Mahjoob K, Holland RD, Beger RD, Thompson K, Hanig J, Sadrieh N. Age-related differences in susceptibility to cisplatin-induced renal toxicity. J Appl Toxicol 2010;30:172-82. [PMID: 19839026 DOI: 10.1002/jat.1484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
37 Chauhan P, Sodhi A, Tarang S. Cisplatin-treated murine peritoneal macrophages induce apoptosis in L929 cells: role of Fas-Fas ligand and tumor necrosis factor-tumor necrosis factor receptor 1. Anticancer Drugs 2007;18:187-96. [PMID: 17159605 DOI: 10.1097/CAD.0b013e3280104b11] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 El-Naga RN, Mahran YF. Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1. Sci Rep 2016;6:29857. [PMID: 27417335 DOI: 10.1038/srep29857] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
39 Thushara RM, Hemshekhar M, Kemparaju K, Rangappa KS, Devaraja S, Girish KS. Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology. Arch Toxicol 2014;88:185-98. [PMID: 24363025 DOI: 10.1007/s00204-013-1185-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
40 Maheshwari RA, Sailor GU, Patel L, Balaraman R. Amelioration of cisplatin-induced nephrotoxicity by statins. Indian J Pharmacol 2013;45:354-8. [PMID: 24014910 DOI: 10.4103/0253-7613.115016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
41 El-naga RN. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: Impact on NOX-1, inflammation and apoptosis. Toxicology and Applied Pharmacology 2014;274:87-95. [DOI: 10.1016/j.taap.2013.10.031] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 8.9] [Reference Citation Analysis]
42 Saif-Elnasr M, Abdel-Aziz N, El-Batal AI. Ameliorative effect of selenium nanoparticles and fish oil on cisplatin and gamma irradiation-induced nephrotoxicity in male albino rats. Drug Chem Toxicol 2019;42:94-103. [PMID: 30203673 DOI: 10.1080/01480545.2018.1497050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Mitazaki S, Hashimoto M, Matsuhashi Y, Honma S, Suto M, Kato N, Nakagawasai O, Tan-no K, Hiraiwa K, Yoshida M, Abe S. Interleukin-6 modulates oxidative stress produced during the development of cisplatin nephrotoxicity. Life Sciences 2013;92:694-700. [DOI: 10.1016/j.lfs.2013.01.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
44 An Y, Xin H, Yan W, Zhou X. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Experimental and Toxicologic Pathology 2011;63:215-9. [DOI: 10.1016/j.etp.2009.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
45 Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123:1227-1239. [PMID: 18623084 DOI: 10.1002/ijc.23754] [Cited by in Crossref: 137] [Cited by in F6Publishing: 119] [Article Influence: 10.5] [Reference Citation Analysis]
46 Prakash J, de Borst MH, van Loenen-weemaes AM, Lacombe M, Opdam F, van Goor H, Meijer DKF, Moolenaar F, Poelstra K, Kok RJ. Cell-specific Delivery of a Transforming Growth Factor-beta Type I Receptor Kinase Inhibitor to Proximal Tubular Cells for the Treatment of Renal Fibrosis. Pharm Res 2008;25:2427-39. [DOI: 10.1007/s11095-007-9515-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
47 Sánchez-gonzález PD, López-hernández FJ, López-novoa JM, Morales AI. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Critical Reviews in Toxicology 2011;41:803-21. [DOI: 10.3109/10408444.2011.602662] [Cited by in Crossref: 134] [Cited by in F6Publishing: 136] [Article Influence: 13.4] [Reference Citation Analysis]
48 Abdel-Daim MM, El-Sayed YS, Eldaim MA, Ibrahim A. Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats. Naunyn Schmiedebergs Arch Pharmacol 2017;390:301-9. [PMID: 27975300 DOI: 10.1007/s00210-016-1332-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
49 Harisa GI. Benfotiamine enhances antioxidant defenses and protects against cisplatin-induced DNA damage in nephrotoxic rats. J Biochem Mol Toxicol 2013;27:398-405. [PMID: 23716490 DOI: 10.1002/jbt.21501] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Flávio AG, Cunha FQ, Francescato HDC, Soares TJ, Costa RS, Barbosa Júnior F, Coimbra TM. ATP-Sensitive Potassium Channel Blockage Attenuates Cisplatin-Induced Renal Damage. Kidney Blood Press Res 2007;30:289-98. [DOI: 10.1159/000105816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Yasueda A, Urushima H, Ito T. Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review. Integr Cancer Ther 2016;15:17-39. [PMID: 26503419 DOI: 10.1177/1534735415610427] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 11.3] [Reference Citation Analysis]
52 Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Rev Nephrol 2006;2:80-91. [DOI: 10.1038/ncpneph0076] [Cited by in Crossref: 195] [Cited by in F6Publishing: 145] [Article Influence: 13.0] [Reference Citation Analysis]
53 Csongradi E, Juncos LA, Drummond HA, Vera T, Stec DE. Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney? Curr Pharm Biotechnol 2012;13:819-26. [PMID: 22201605 DOI: 10.2174/138920112800399284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
54 Uehara T, Miyoshi T, Tsuchiya N, Masuno K, Okada M, Inoue S, Torii M, Yamate J, Maruyama T. Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats. Hum Exp Toxicol 2007;26:767-80. [DOI: 10.1177/0960327107084069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
55 Yu Y, Chen H, Li Y. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice. Arch Toxicol 2009;83:381-7. [DOI: 10.1007/s00204-008-0370-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
56 Campbell KCM, Fox DJ. Cisplatin-Induced Hearing Loss. In: Le Prell CG, Lobarinas E, Popper AN, Fay RR, editors. Translational Research in Audiology, Neurotology, and the Hearing Sciences. Cham: Springer International Publishing; 2016. pp. 141-64. [DOI: 10.1007/978-3-319-40848-4_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
57 Hsing CH, Tsai CC, Chen CL, Lin YH, Tseng PC, Satria RD, Lin CF. Pharmacologically Inhibiting Glycogen Synthase Kinase-3β Ameliorates Renal Inflammation and Nephrotoxicity in an Animal Model of Cisplatin-Induced Acute Kidney Injury. Biomedicines 2021;9:887. [PMID: 34440091 DOI: 10.3390/biomedicines9080887] [Reference Citation Analysis]
58 Wei Q, Dong G, Franklin J, Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 2007;72:53-62. [PMID: 17410096 DOI: 10.1038/sj.ki.5002256] [Cited by in Crossref: 152] [Cited by in F6Publishing: 150] [Article Influence: 10.9] [Reference Citation Analysis]
59 Mense ES, Smit AAJ, Crul M, Franssen EJF. The effect of rapid infusion of cisplatin on nephrotoxicity in patients with lung carcinoma. J Clin Pharm Ther 2019;44:249-57. [DOI: 10.1111/jcpt.12781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Custódio JB, Cardoso CM, Santos MS, Almeida LM, Vicente JA, Fernandes MA. Cisplatin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology 2009;259:18-24. [PMID: 19428939 DOI: 10.1016/j.tox.2009.01.022] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
61 Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD. Long-Term Renal Outcomes after Cisplatin Treatment. Clin J Am Soc Nephrol 2016;11:1173-9. [PMID: 27073199 DOI: 10.2215/CJN.08070715] [Cited by in Crossref: 67] [Cited by in F6Publishing: 38] [Article Influence: 13.4] [Reference Citation Analysis]
62 Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5:22. [PMID: 17125495 DOI: 10.1186/jbiol50] [Cited by in Crossref: 313] [Cited by in F6Publishing: 300] [Article Influence: 22.4] [Reference Citation Analysis]
63 Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC Jr, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy. Clin Cancer Res 2019;25:5913-24. [PMID: 31296530 DOI: 10.1158/1078-0432.CCR-19-0113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
64 Santucci R, Sinibaldi F, Cozza P, Polticelli F, Fiorucci L. Cytochrome c: An extreme multifunctional protein with a key role in cell fate. International Journal of Biological Macromolecules 2019;136:1237-46. [DOI: 10.1016/j.ijbiomac.2019.06.180] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 23.0] [Reference Citation Analysis]
65 Spalato M, Italiano A. The safety of current pharmacotherapeutic strategies for osteosarcoma. Expert Opin Drug Saf 2021;20:427-38. [PMID: 33478264 DOI: 10.1080/14740338.2021.1881060] [Reference Citation Analysis]
66 Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2010;2:2490-518. [PMID: 22069563 DOI: 10.3390/toxins2112490] [Cited by in Crossref: 782] [Cited by in F6Publishing: 727] [Article Influence: 71.1] [Reference Citation Analysis]
67 Kusumoto M, Kamobayashi H, Sato D, Komori M, Yoshimura M, Hamada A, Kohda Y, Tomita K, Saito H. Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats. Clin Exp Nephrol 2011;15:820-30. [PMID: 21858734 DOI: 10.1007/s10157-011-0524-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
68 Bao H, Zhang Q, Liu X, Song Y, Li X, Wang Z, Li C, Peng A, Gong R. Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells. FASEB J 2019;33:14370-81. [PMID: 31661633 DOI: 10.1096/fj.201901712R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
69 Miyata Y, Sakai H. Anti-Cancer and Protective Effects of Royal Jelly for Therapy-Induced Toxicities in Malignancies. Int J Mol Sci 2018;19:E3270. [PMID: 30347885 DOI: 10.3390/ijms19103270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
70 Uehara T, Tsuchiya N, Masuda A, Torii M, Nakamura M, Yamate J, Maruyama T. Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats. J Appl Toxicol 2008;28:388-98. [PMID: 17685399 DOI: 10.1002/jat.1292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
71 Moon HH, Seo KW, Yoon KY, Shin YM, Choi KH, Lee SH. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients. World J Gastroenterol 2011; 17(30): 3510-3517 [PMID: 21941418 DOI: 10.3748/wjg.v17.i30.3510] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
72 Brahmi D, Ayed Y, Hfaiedh M, Bouaziz C, Mansour HB, Zourgui L, Bacha H. Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition. BMC Complement Altern Med 2012;12:111. [PMID: 22849573 DOI: 10.1186/1472-6882-12-111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
73 Won AJ, Kim S, Kim YG, Kim KB, Choi WS, Kacew S, Kim KS, Jung JH, Lee BM, Kim S, Kim HS. Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury. Mol Biosyst 2016;12:133-44. [PMID: 26566257 DOI: 10.1039/c5mb00492f] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 9.4] [Reference Citation Analysis]
74 Rjiba-Touati K, Boussema IA, Belarbia A, Achour A, Bacha H. Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney. Int J Toxicol 2011;30:510-7. [PMID: 22013135 DOI: 10.1177/1091581810411931] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
75 Firdous AP, Kuttan R. Amelioration of cisplatin-induced toxicity in mice by carotenoid meso-zeaxanthin. Hum Exp Toxicol 2012;31:710-7. [PMID: 22241628 DOI: 10.1177/0960327111431707] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
76 Kuriakose GC, Kurup MG. Effects of Aulosira fertilisima against cisplatin-induced nephrotoxicity and oxidative stress in rats. Ren Fail 2010;32:224-33. [PMID: 20199185 DOI: 10.3109/08860220903541143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
77 Ku JM, Hong SH, Kim HI, Kim MJ, Kim SK, Kim M, Choi SY, Park J, Kim HK, Kim JH, Seo HS, Shin YC, Ko SG. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. Phytomedicine 2020;66:153109. [PMID: 31790894 DOI: 10.1016/j.phymed.2019.153109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 dos Santos NAG, dos Santos AC. Antioxidants and Inhibition of Cisplatin-Induced Kidney Injury: Role of Mitochondria. In: Spitz DR, Dornfeld KJ, Krishnan K, Gius D, editors. Oxidative Stress in Cancer Biology and Therapy. Totowa: Humana Press; 2012. pp. 407-25. [DOI: 10.1007/978-1-61779-397-4_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
79 Arafa HM, Abdel-Hamid MA, El-Khouly AA, Elmazar MM, Osman AM. Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm. Toxicology 2006;222:103-13. [PMID: 16567030 DOI: 10.1016/j.tox.2006.02.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
80 Bennis Y, Savry A, Rocca M, Gauthier-villano L, Pisano P, Pourroy B. Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow? Int J Clin Pharm 2014;36:420-9. [DOI: 10.1007/s11096-013-9912-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
81 Hassan MS, Morgan AM, Mekawy MM, Zeineb M. Molecular mechanisms of Cisplatin- induced placental toxicity and teratogenicity in rats and the ameliorating role of N-acetyl-cysteine. The International Journal of Biochemistry & Cell Biology 2019;115:105579. [DOI: 10.1016/j.biocel.2019.105579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yousef MI, Hussien HM. Cisplatin-induced renal toxicity via tumor necrosis factor-α, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: Protective effect of ginseng. Food and Chemical Toxicology 2015;78:17-25. [DOI: 10.1016/j.fct.2015.01.014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
83 Baek SH, Shin BK, Kim NJ, Chang SY, Park JH. Protective effect of ginsenosides Rk3 and Rh4 on cisplatin-induced acute kidney injury in vitro and in vivo. J Ginseng Res 2017;41:233-9. [PMID: 28701862 DOI: 10.1016/j.jgr.2016.03.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
84 Ko J, Tsai C, Liu T, Lin M, Lin H, Ou C. Differential effects of grape juice on gastric emptying and renal function from cisplatin-induced acute adverse toxicity. Hum Exp Toxicol 2016;35:808-17. [DOI: 10.1177/0960327115607079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
85 Sahin K, Sahin N, Kucuk O. Lycopene and Chemotherapy Toxicity. Nutrition and Cancer 2010;62:988-95. [DOI: 10.1080/01635581.2010.509838] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
86 Sharma V, Srinivasan A, Roychoudhury A, Rani K, Tyagi M, Dev K, Nikolajeff F, Kumar S. Characterization of protein extracts from different types of human teeth and insight in biomineralization. Sci Rep 2019;9:9314. [PMID: 31249316 DOI: 10.1038/s41598-019-44268-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
87 Campos-Arroyo D, Maldonado V, Bahena I, Quintanar V, Patiño N, Carlos Martinez-Lazcano J, Melendez-Zajgla J. Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin. Cancer Invest 2016;34:155-66. [PMID: 26963048 DOI: 10.3109/07357907.2016.1139717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
88 Rjiba-Touati K, Ayed-Boussema I, Skhiri H, Belarbia A, Zellema D, Achour A, Bacha H. Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: protective effect of recombinant human erythropoietin. Mutat Res 2012;747:202-6. [PMID: 22664391 DOI: 10.1016/j.mrgentox.2012.05.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
89 Ali BH. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature. Basic Clin Pharmacol Toxicol 2010;106:272-9. [PMID: 20050845 DOI: 10.1111/j.1742-7843.2009.00512.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
90 Rjiba-Touati K, Ayed-Boussema I, Belarbia A, Azzebi A, Achour A, Bacha H. Protective effect of recombinant human erythropoeitin against cisplatin cytotoxicity and genotoxicity in cultured Vero cells. Exp Toxicol Pathol 2013;65:181-7. [PMID: 21924599 DOI: 10.1016/j.etp.2011.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
91 Schacht J, Talaska AE, Rybak LP. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken). 2012;295:1837-1850. [PMID: 23045231 DOI: 10.1002/ar.22578] [Cited by in Crossref: 188] [Cited by in F6Publishing: 173] [Article Influence: 20.9] [Reference Citation Analysis]
92 Miltiadous G, Christidis D, Kalogirou M, Elisaf M. Causes and mechanisms of acid–base and electrolyte abnormalities in cancer patients. European Journal of Internal Medicine 2008;19:1-7. [DOI: 10.1016/j.ejim.2007.04.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
93 Park JH, Jang HR, Kim DH, Kwon GY, Lee JE, Huh W, Choi SJ, Oh W, Oh HY, Kim YG. Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. Am J Physiol Renal Physiol 2017;313:F984-96. [PMID: 28356286 DOI: 10.1152/ajprenal.00097.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
94 Chiarandini Fiore JP, Fanelli SL, de Ferreyra EC, Castro JA. Diallyl Disulfide Prevention of Cis-Diammine Dichloroplatinum–Induced Nephrotoxicity and Leukopenia in Rats: Potential Adjuvant Effects. Nutrition and Cancer 2008;60:784-91. [DOI: 10.1080/01635580802100869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
95 Osama H, Abdullah A, Gamal B, Emad D, Sayed D, Hussein E, Mahfouz E, Tharwat J, Sayed S, Medhat S, Bahaa T, Abdelrahim MEA. Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer. J Am Coll Nutr 2017;36:342-6. [PMID: 28548561 DOI: 10.1080/07315724.2017.1292157] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
96 Abdelhamid AM, Mahmoud SS, Abdelrahman AE, Said NM, Toam M, Samy W, Amer MA. Protective effect of cerium oxide nanoparticles on cisplatin and oxaliplatin primary toxicities in male albino rats. Naunyn Schmiedebergs Arch Pharmacol 2020;393:2411-25. [PMID: 32710137 DOI: 10.1007/s00210-020-01946-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Panahi Y, Saadat A, Beiraghdar F, Hosseini Nouzari SM, Jalalian HR, Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. Journal of Functional Foods 2014;6:615-22. [DOI: 10.1016/j.jff.2013.12.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 6.9] [Reference Citation Analysis]
98 Wang C, Dai H, Xiong Z, Song Q, Zou Z, Li M, Nie J, Bai X, Chen Z. Loss of DEPTOR in renal tubules protects against cisplatin-induced acute kidney injury. Cell Death Dis 2018;9:441. [PMID: 29670094 DOI: 10.1038/s41419-018-0483-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
99 Francescato HD, Costa RS, da Silva CG, Coimbra TM. Treatment with a p38 MAPK inhibitor attenuates cisplatin nephrotoxicity starting after the beginning of renal damage. Life Sciences 2009;84:590-7. [DOI: 10.1016/j.lfs.2009.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
100 Moghadasali R, Hajinasrollah M, Argani H, Nassiri SM, Najarasl M, Sodeifi N, Baharvand H, Aghdami N. Autologous transplantation of mesenchymal stromal cells tends to prevent progress of interstitial fibrosis in a rhesus Macaca mulatta monkey model of chronic kidney disease. Cytotherapy. 2015;17:1495-1505. [PMID: 26341479 DOI: 10.1016/j.jcyt.2015.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
101 Wang J, Pabla N, Wang CY, Wang W, Schoenlein PV, Dong Z. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53. Am J Physiol Renal Physiol 2006;291:F1300-7. [PMID: 16849690 DOI: 10.1152/ajprenal.00509.2005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
102 Csongradi E, Vera T, Rimoldi JM, Gadepalli RS, Stec DE. In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor. Pharmacol Res 2010;61:525-30. [PMID: 20338241 DOI: 10.1016/j.phrs.2010.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
103 Chtourou Y, Aouey B, Aroui S, Kebieche M, Fetoui H. Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat. Chemico-Biological Interactions 2016;243:1-9. [DOI: 10.1016/j.cbi.2015.11.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
104 Doğan S, Yazici H, Yalçinkaya E, Erdoğdu HI, Tokgöz SA, Sarici F, Namuslu M, Sarikaya Y. Protective Effect of Selenium Against Cisplatin-Induced Ototoxicity in an Experimental Design. J Craniofac Surg 2016;27:e610-4. [PMID: 27741210 DOI: 10.1097/SCS.0000000000002942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
105 Lee H, Lee D, Kang KS, Song JH, Choi YK. Inhibition of Intracellular ROS Accumulation by Formononetin Attenuates Cisplatin-Mediated Apoptosis in LLC-PK1 Cells. Int J Mol Sci 2018;19:E813. [PMID: 29534504 DOI: 10.3390/ijms19030813] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
106 Naqshbandi A, Khan W, Rizwan S, Khan F. Studies on the protective effect of flaxseed oil on cisplatin-induced hepatotoxicity. Hum Exp Toxicol 2012;31:364-75. [DOI: 10.1177/0960327111432502] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
107 Galfetti E, Cerutti A, Ghielmini M, Zucca E, Wannesson L. Risk factors for renal toxicity after inpatient cisplatin administration. BMC Pharmacol Toxicol 2020;21:19. [PMID: 32122396 DOI: 10.1186/s40360-020-0398-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Campos-arroyo D, Martínez-lazcano JC, Melendez-zajgla J. Probenecid is a chemosensitizer in cancer cell lines. Cancer Chemother Pharmacol 2012;69:495-504. [DOI: 10.1007/s00280-011-1725-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
109 Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009;64:753-761. [PMID: 19148645 DOI: 10.1007/s00280-008-0924-2] [Cited by in Crossref: 117] [Cited by in F6Publishing: 107] [Article Influence: 9.8] [Reference Citation Analysis]
110 Tamadon MR, Tirom S, Ghahremanfard F, Baradaran A, Ghorbani R. Evaluation of the Protective Effect of Cystone Against Cisplatin-induced Nephrotoxicity in Patients with Cancer: A Pilot Study. Int J Prev Med 2019;10:180. [PMID: 32133098 DOI: 10.4103/ijpvm.IJPVM_66_18] [Reference Citation Analysis]
111 Salazar-garcía S, Silva-ramírez AS, Ramirez-lee MA, Rosas-hernandez H, Rangel-lópez E, Castillo CG, Santamaría A, Martinez-castañon GA, Gonzalez C. Comparative effects on rat primary astrocytes and C6 rat glioma cells cultures after 24-h exposure to silver nanoparticles (AgNPs). J Nanopart Res 2015;17. [DOI: 10.1007/s11051-015-3257-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
112 Barregard L, Elinder C. Renal Effects of Exposure to Metals. Handbook on the Toxicology of Metals. Elsevier; 2015. pp. 333-50. [DOI: 10.1016/b978-0-444-59453-2.00017-2] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
113 Kuriakose GC, Kurup MG. Evaluation of renoprotective effect of Aphanizomenon flos-aquae on cisplatin-induced renal dysfunction in rats. Ren Fail 2008;30:717-25. [PMID: 18704821 DOI: 10.1080/08860220802134730] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
114 Sin EI, Chia CS, Tan GHC, Soo KC, Teo MC. Acute kidney injury in ovarian cancer patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Int J Hyperthermia 2017;33:690-5. [PMID: 28540777 DOI: 10.1080/02656736.2017.1293304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
115 Oh GS, Kim HJ, Choi JH, Shen A, Choe SK, Karna A, Lee SH, Jo HJ, Yang SH, Kwak TH, Lee CH, Park R, So HS. Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice. Kidney Int 2014;85:547-60. [PMID: 24025646 DOI: 10.1038/ki.2013.330] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 9.8] [Reference Citation Analysis]
116 Nozaki Y, Nikolic-Paterson DJ, Yagita H, Akiba H, Holdsworth SR, Kitching AR. Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2011;301:F1098-104. [PMID: 21835770 DOI: 10.1152/ajprenal.00193.2011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
117 Longo V, Gervasi P, Lubrano V. Cisplatin induced toxicity in rat tissues: The protective effect of Lisosan G. Food and Chemical Toxicology 2011;49:233-7. [DOI: 10.1016/j.fct.2010.10.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
118 Nannelli A, Messina A, Marini S, Trasciatti S, Longo V, Gervasi PG. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues. Arch Toxicol 2007;81:479-87. [DOI: 10.1007/s00204-007-0184-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
119 Ali BH, Al Moundhri MS, Tag Eldin M, Nemmar A, Tanira MO. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundam Clin Pharmacol 2007;21:547-53. [PMID: 17868208 DOI: 10.1111/j.1472-8206.2007.00495.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
120 Saad SY, Arafah MM, Najjar TA. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats. Cancer Chemother Pharmacol 2007;59:455-60. [DOI: 10.1007/s00280-006-0284-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
121 Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, Yusufi AN. Studies on the protective effect of green tea against cisplatin induced nephrotoxicity. Pharmacol Res 2009;60:382-91. [PMID: 19647078 DOI: 10.1016/j.phrs.2009.07.007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
122 Rastghalam R, Nematbakhsh M, Bahadorani M, Eshraghi-Jazi F, Talebi A, Moeini M, Ashrafi F, Shirdavani S. Angiotensin Type-1 Receptor Blockade May Not Protect Kidney against Cisplatin-Induced Nephrotoxicity in Rats. ISRN Nephrol 2014;2014:479645. [PMID: 24967243 DOI: 10.1155/2014/479645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
123 Mizuno T, Sato W, Ishikawa K, Shinjo H, Miyagawa Y, Noda Y, Imai E, Yamada K. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury. Oncology 2012;82:354-9. [PMID: 22722365 DOI: 10.1159/000338664] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
124 Hartlev LB, Boeje CR, Bluhme H, Palshof T, Rehling M. Monitoring renal function during chemotherapy. Eur J Nucl Med Mol Imaging 2012;39:1478-82. [PMID: 22699525 DOI: 10.1007/s00259-012-2158-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
125 Ali BH, Abdelrahman AM, Al-Salam S, Sudhadevi M, AlMahruqi AS, Al-Husseni IS, Beegam S, Dhanasekaran S, Nemmar A, Al-Moundhri M. The effect of sildenafil on cisplatin nephrotoxicity in rats. Basic Clin Pharmacol Toxicol 2011;109:300-8. [PMID: 21575139 DOI: 10.1111/j.1742-7843.2011.00724.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
126 Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007;33:407-18. [PMID: 17367938 DOI: 10.1016/j.ctrv.2007.01.005] [Cited by in Crossref: 142] [Cited by in F6Publishing: 106] [Article Influence: 10.1] [Reference Citation Analysis]
127 Yamabe N, Park JY, Lee S, Cho E, Lee S, Kang KS, Hwang GS, Kim S, Kim HY, Shibamoto T. Protective effects of protocatechuic acid against cisplatin-induced renal damage in rats. Journal of Functional Foods 2015;19:20-7. [DOI: 10.1016/j.jff.2015.08.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
128 Alkhamees OA, Alroujayee AS, Abuohashish HM, Alrojayee FS, Ahmed MM. Possible involvement of the lipoxygenase and leukotriene signaling pathways in cisplatin-mediated renal toxicity. Cancer Chemother Pharmacol 2017;80:55-64. [DOI: 10.1007/s00280-017-3331-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
129 Jiang M, Wang CY, Huang S, Yang T, Dong Z. Cisplatin-induced apoptosis in p53-deficient renal cells via the intrinsic mitochondrial pathway. Am J Physiol Renal Physiol 2009;296:F983-93. [PMID: 19279129 DOI: 10.1152/ajprenal.90579.2008] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 5.9] [Reference Citation Analysis]
130 Farooqui Z, Ahmed F, Rizwan S, Shahid F, Khan AA, Khan F. Protective effect of Nigella sativa oil on cisplatin induced nephrotoxicity and oxidative damage in rat kidney. Biomedicine & Pharmacotherapy 2017;85:7-15. [DOI: 10.1016/j.biopha.2016.11.110] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
131 Toffart AC, Belaiche S, Moro-Sibilot D, Couraud S, Sakhri L. [Impact of lung cancer treatments on renal function]. Rev Mal Respir 2014;31:1003-12. [PMID: 25496793 DOI: 10.1016/j.rmr.2014.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
132 Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007;230:64-75. [PMID: 17156909 DOI: 10.1016/j.tox.2006.10.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
133 Rosic G, Selakovic D, Joksimovic J, Srejovic I, Zivkovic V, Tatalović N, Orescanin-dusic Z, Mitrovic S, Ilic M, Jakovljevic V. The effects of N -acetylcysteine on cisplatin-induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts. Toxicology Letters 2016;242:34-46. [DOI: 10.1016/j.toxlet.2015.11.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
134 Hassan HA, Edrees GM, El-Gamel EM, El-Sayed EA. Amelioration of cisplatin-induced nephrotoxicity by grape seed extract and fish oil is mediated by lowering oxidative stress and DNA damage. Cytotechnology 2014;66:419-29. [PMID: 23761012 DOI: 10.1007/s10616-013-9589-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
135 Selting K, Waldrep JC, Reinero C, Branson K, Gustafson D, Kim DY, Henry C, Owen N, Madsen R, Dhand R. Feasibility and Safety of Targeted Cisplatin Delivery to a Select Lung Lobe in Dogs via the AeroProbe ® Intracorporeal Nebulization Catheter. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2008;21:255-68. [DOI: 10.1089/jamp.2008.0684] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
136 Kim H, Park DJ, Kim JH, Jeong EY, Jung MH, Kim T, Yang JI, Lee G, Chung HJ, Chang S. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation. Journal of Pharmacological Sciences 2015;127:117-26. [DOI: 10.1016/j.jphs.2014.11.009] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
137 Taguchi T, Nazneen A, Al-Shihri AA, Turkistani KA, Razzaque MS. Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells. Acta Histochem Cytochem 2011;44:35-41. [PMID: 21614164 DOI: 10.1267/ahc.11001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
138 Kim S, Park C, Han AL, Youn M, Lee J, Kim Y, Kim E, Kim H, Kim J, Lee H, Chung S, So H, Park R. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells. Hearing Research 2009;251:70-82. [DOI: 10.1016/j.heares.2009.03.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
139 Mata-Miranda MM, Bernal-Barquero CE, Martinez-Cuazitl A, Guerrero-Robles CI, Sanchez-Monroy V, Rojas-Lopez M, Vazquez-Zapien GJ. Nephroprotective Effect of Embryonic Stem Cells Reducing Lipid Peroxidation in Kidney Injury Induced by Cisplatin. Oxid Med Cell Longev 2019;2019:5420624. [PMID: 31001374 DOI: 10.1155/2019/5420624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
140 Verma PK, Raina R, Sultana M, Singh M, Kumar P. Total antioxidant and oxidant status of plasma and renal tissue of cisplatin-induced nephrotoxic rats: protection by floral extracts of Calendula officinalis Linn. Ren Fail 2016;38:142-50. [PMID: 26513373 DOI: 10.3109/0886022X.2015.1103585] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
141 Bilgin G, Kismet K, Kuru S, Kaya F, Senes M, Bayrakceken Y, Yumusak N, Celikkan F, Erdemli E, Celemli O, Sorkun K, Koca G. Ultrastructural investigation of the protective effects of propolis on bleomycin induced pulmonary fibrosis. Biotechnic & Histochemistry 2016;91:195-203. [DOI: 10.3109/10520295.2015.1123294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
142 Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, Dong Z. Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 2007;282:2636-45. [PMID: 17130128 DOI: 10.1074/jbc.M606928200] [Cited by in Crossref: 78] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
143 Sharma M, Sehgal R, Kaur S. Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis. PLoS Negl Trop Dis 2012;6:e1629. [PMID: 22563510 DOI: 10.1371/journal.pntd.0001629] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
144 Bulacio RP, Torres AM. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity. Arch Toxicol 2013;87:1953-62. [PMID: 23649842 DOI: 10.1007/s00204-013-1062-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
145 Zuo Z, Lei H, Wang X, Wang Y, Sonntag W, Sun Z. Aging-related kidney damage is associated with a decrease in klotho expression and an increase in superoxide production. Age (Dordr) 2011;33:261-74. [PMID: 20830528 DOI: 10.1007/s11357-010-9176-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
146 Cao X, Zhang W, Moore PK, Bian J. Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity. Int J Mol Sci 2019;20:E313. [PMID: 30646560 DOI: 10.3390/ijms20020313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
147 Sanchez-gonzalez PD, Lopez-hernandez FJ, Perez-barriocanal F, Morales AI, Lopez-novoa JM. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrology Dialysis Transplantation 2011;26:3484-95. [DOI: 10.1093/ndt/gfr195] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 9.5] [Reference Citation Analysis]
148 Rosner MH, Capasso G, Perazella MA. Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care 2017;23:475-83. [PMID: 28953555 DOI: 10.1097/MCC.0000000000000450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 5.3] [Reference Citation Analysis]